These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24025977)

  • 21. Critical flicker frequency as a marker of hepatic encephalopathy in patients before and after transjugular intrahepatic portosystemic shunt.
    Biecker E; Hausdörfer I; Grünhage F; Strunk H; Sauerbruch T
    Digestion; 2011; 83(1-2):24-31. PubMed ID: 20847560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simplified psychometric evaluation for the diagnosis of minimal hepatic encephalopathy.
    Riggio O; Ridola L; Pasquale C; Pentassuglio I; Nardelli S; Moscucci F; Merli M; Montagnese S; Amodio P; Merkel C
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):613-6.e1. PubMed ID: 21440091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relation between pathogenesis of liver cirrhosis, hepatic encephalopathy and serum cytokine levels: what is the role of tumor necrosis factor α?
    Goral V; Atayan Y; Kaplan A
    Hepatogastroenterology; 2011; 58(107-108):943-8. PubMed ID: 21830421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlations among the serum levels of some interleukins and the histopathological aspects in chronic viral hepatitis C.
    Avrămescu CS; Comănescu V; Popescu SN; Turculeanu A; Bălăşoiu M; Popescu CF; Lungulescu M
    Rom J Morphol Embryol; 2008; 49(1):57-62. PubMed ID: 18273504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic encephalopathy is related to anemia and fat-free mass depletion in liver transplant candidates with cirrhosis.
    Kalaitzakis E; Josefsson A; Castedal M; Henfridsson P; Bengtsson M; Andersson B; Björnsson E
    Scand J Gastroenterol; 2013 May; 48(5):577-84. PubMed ID: 23452072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a three-factor neuropsychological approach for detecting minimal hepatic encephalopathy.
    Stewart CA; Enders FT; Schneider N; Felmlee-Devine D; Kamath PS; Smith GE
    Liver Int; 2010 Jul; 30(6):841-9. PubMed ID: 20412441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study.
    Sanyal A; Younossi ZM; Bass NM; Mullen KD; Poordad F; Brown RS; Vemuru RP; Mazen Jamal M; Huang S; Merchant K; Bortey E; Forbes WP
    Aliment Pharmacol Ther; 2011 Oct; 34(8):853-61. PubMed ID: 21848797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non invasive blood flow measurement in cerebellum detects minimal hepatic encephalopathy earlier than psychometric tests.
    Felipo V; Urios A; Giménez-Garzó C; Cauli O; Andrés-Costa MJ; González O; Serra MA; Sánchez-González J; Aliaga R; Giner-Durán R; Belloch V; Montoliu C
    World J Gastroenterol; 2014 Sep; 20(33):11815-25. PubMed ID: 25206287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Sharma BC; Agrawal A; Sarin SK
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between interleukin-6 and ammonia in patients with overt hepatic encephalopathy due to cirrhosis.
    Luo M; Li L; Yang EN; Dai CY; Liang SR; Cao WK
    Clin Res Hepatol Gastroenterol; 2013 Sep; 37(4):384-90. PubMed ID: 23084463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving the inhibitory control task to detect minimal hepatic encephalopathy.
    Amodio P; Ridola L; Schiff S; Montagnese S; Pasquale C; Nardelli S; Pentassuglio I; Trezza M; Marzano C; Flaiban C; Angeli P; Cona G; Bisiacchi P; Gatta A; Riggio O
    Gastroenterology; 2010 Aug; 139(2):510-8, 518.e1-2. PubMed ID: 20470775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ammonia levels and the severity of hepatic encephalopathy.
    Qureshi MO; Khokhar N; Shafqat F
    J Coll Physicians Surg Pak; 2014 Mar; 24(3):160-3. PubMed ID: 24613109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of therapeutic effects of gabexate mesilate on the hepatic encephalopathy in rats with acute and chronic hepatic failure.
    Hsu CY; Lee FY; Huo TI; Chan CY; Huang HC; Lin HC; Chang CC; Teng TH; Wang SS; Lee SD
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1321-8. PubMed ID: 20594263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased risk of cognitive impairment in cirrhotic patients with bacterial infections.
    Merli M; Lucidi C; Pentassuglio I; Giannelli V; Giusto M; Di Gregorio V; Pasquale C; Nardelli S; Lattanzi B; Venditti M; Riggio O
    J Hepatol; 2013 Aug; 59(2):243-50. PubMed ID: 23523580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Covert hepatic encephalopathy: agreement and predictive validity of different indices.
    Montagnese S; Balistreri E; Schiff S; De Rui M; Angeli P; Zanus G; Cillo U; Bombonato G; Bolognesi M; Sacerdoti D; Gatta A; Merkel C; Amodio P
    World J Gastroenterol; 2014 Nov; 20(42):15756-62. PubMed ID: 25400460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis.
    Gundling F; Schmidtler F; Hapfelmeier A; Schulte B; Schmidt T; Pehl C; Schepp W; Seidl H
    Liver Int; 2011 Oct; 31(9):1406-15. PubMed ID: 22093455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Night-time sleep disturbance does not correlate with neuropsychiatric impairment in patients with cirrhosis.
    Montagnese S; Middleton B; Skene DJ; Morgan MY
    Liver Int; 2009 Oct; 29(9):1372-82. PubMed ID: 19686311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of hyponatremia with hepatic encephalopathy and severity of liver disease.
    Qureshi MO; Khokhar N; Saleem A; Niazi TK
    J Coll Physicians Surg Pak; 2014 Feb; 24(2):135-7. PubMed ID: 24491011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for minimal hepatic encephalopathy in asymptomatic drivers with liver cirrhosis.
    Gad YZ; Zaher AA; Moussa NH; El-desoky AE; Al-Adarosy HA
    Arab J Gastroenterol; 2011 Jun; 12(2):58-61. PubMed ID: 21684474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic Encephalopathy Aggravated by Systemic Inflammation.
    Manzhalii E; Virchenko O; Falalyeyeva T; Moiseienko V; Nykula T; Kondratiuk V; Savchuk O; Beregova T; Stremmel W
    Dig Dis; 2019; 37(6):509-517. PubMed ID: 31170723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.